Home » Topics » BioWorld Science

BioWorld Science
RSS

Anxiolytic effect for JNJ-61393215 seen in humans

June 5, 2019

AZP-3404 restores glucose homeostasis in leptin-deficient obese mice

June 5, 2019

FDA accepts Prevail's IND for phase I/II study of PR-001 for Parkinson's disease with GBA1 mutation

June 5, 2019

FDA approves Emgality for episodic cluster headache

June 5, 2019

Oncolytic virus works in pediatric brain tumors

June 5, 2019

Cellenkos initiates phase I trial of CK-0801 for bone marrow failure syndromes

June 5, 2019

Safety results from CITN-12 study on pembrolizumab in patients with HIV and cancer

June 5, 2019

Teligene discloses Bruton tyrosine kinase and/or HER2 inhibitors

June 5, 2019

New slective estrogen receptor degraders identified at Anlin Pharmaceuticals

June 5, 2019

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery patent anti-HBV compounds

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...